| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |